News Merck appeals rofecoxib verdict BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39157.476910.DB (Published 22 March 2007) Cite this as: BMJ 2007;334:607 Article Related content Metrics Responses Peer review Related articles Feature What have we learnt from Vioxx? Published: 18 January 2007; BMJ 334 doi:10.1136/bmj.39024.487720.68 See more Zika related microcephaly may appear after birth, study finds BMJ November 23, 2016, 355 i6333; DOI: https://doi.org/10.1136/bmj.i6333 NHS spent 8% more on medicines last year BMJ November 23, 2016, 355 i6320; DOI: https://doi.org/10.1136/bmj.i6320 Supervised physiotherapy for mild or moderate ankle sprain BMJ November 16, 2016, 355 i5984; DOI: https://doi.org/10.1136/bmj.i5984 US adults are more likely to have poor health than those in 10 similar countries, survey finds BMJ November 16, 2016, 355 i6174; DOI: https://doi.org/10.1136/bmj.i6174 Chronic insomnia: diagnosis and non-pharmacological management BMJ November 16, 2016, 355 i5819; DOI: https://doi.org/10.1136/bmj.i5819
